Core Viewpoint - Jingtai Holdings (02228) has seen a significant stock price increase of over 4%, currently trading at HKD 11.92 with a transaction volume of HKD 22.59 billion, following its inclusion in the FTSE China Small Cap Index [1] Group 1: Company Performance - Jingtai Holdings has achieved its first profitable half-year, reporting a revenue of HKD 517 million, which represents a year-on-year growth of 403.8% [1] - The company has secured a substantial order worth nearly USD 6 billion, validating its AI pharmaceutical commercialization capabilities [1] - Adjusted net profit for the first half of the year reached HKD 141.6 million, marking the first time the company has reported a half-year profit [1] Group 2: Market Impact - The inclusion in the FTSE Global Equity Index Series indicates broader capital attention and potential liquidity premium for Jingtai Holdings [1] - The adjustment to the index took effect after the market close on September 19, enhancing the company's visibility in the international market [1]
晶泰控股涨超4% 近日获纳入富时中国小盘股 AI制药商业化能力获得验证